Integra LifeSciences to Present at Three Conferences in February
February 02 2012 - 9:43AM
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced
today that it will present at the following conferences this month:
- At 2:00 PM PT on Tuesday, February 7, 2012, Mr. Brian Larkin,
President, Global Spine & Orthobiologics and Head of Strategic
Development of Integra, will present at the Canaccord Genuity
Musculoskeletal Conference in San Francisco, CA. A link to the
webcast for this presentation will be posted on our website on the
Investor Relations section at www.integralife.com.
- At 9:00 AM ET on Tuesday, February 28, 2012, Mr. Peter Arduini,
President and Chief Executive Officer of Integra, will present at
the RBC Capital Markets' Global Healthcare Conference in New York
City. A link to the webcast for this presentation will be
posted on our website on the Investor Relations section at
www.integralife.com.
- At 2:00 PM ET on Tuesday, February 28, 2012, Mr. Arduini will
also present at the Citi Global Health Care Conference in New York
City. This presentation will not be webcast.
Integra LifeSciences, a world leader in medical devices, is
dedicated to limiting uncertainty for surgeons, so they can
concentrate on providing the best patient care. Integra offers
innovative solutions in orthopedics, neurosurgery, spine,
reconstructive and general surgery. For more information, please
visit www.integralife.com
Statements made at the upcoming conferences may be
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements involve risks and uncertainties that could cause actual
results to differ from predicted results. Forward-looking factors
that may be discussed include, but are not limited to, future
financial performance, new product development, governmental
approvals, market potential and resulting sales as well as
potential therapeutic applications, and additional acquisitions.
These risks and uncertainties include market conditions and other
factors beyond the Company's control and the economic, competitive,
governmental, technological and other factors identified under the
heading "Risk Factors" included in item IA of Integra's Annual
Report on Form 10-K for the year ended December 31, 2010 and
information contained in subsequent filings with the Securities and
Exchange Commission could affect actual results. These
forward-looking statements are made only as of the date thereof,
and the Company undertakes no obligation to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise.
CONTACT: Integra LifeSciences Holdings Corporation
John B. Henneman, III
Executive Vice President, Chief Financial Officer
(609) 275-0500
jack.henneman@integralife.com
Investor Relations:
Angela Steinway
(609) 936-2268
angela.steinway@integralife.com
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Aug 2024 to Sep 2024
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Sep 2023 to Sep 2024